Understanding the health risks of La Crosse virus in children

Vector-virus determinants of the public health risk of La Crosse virus in the Northeastern USA

NIH-funded research Virginia Polytechnic Inst and St Univ · NIH-11013926

This study is looking into the La Crosse virus, which can cause serious brain infections in kids under 16, especially in certain parts of the U.S., to learn more about how it spreads through mosquitoes and what it means for children's health, so we can improve diagnosis and prevention.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionVirginia Polytechnic Inst and St Univ NIH-funded
Lab location1 site (Blacksburg, United States)
Project IDNIH-11013926 on NIH RePORTER

What this research studies

This research investigates the La Crosse virus (LACV), a significant cause of pediatric encephalitis in North America, particularly affecting children under 16 in the Appalachian and Midwest regions. The study aims to explore the different lineages of the virus, especially a newly identified lineage in the Northeastern USA, to assess its potential health risks. By examining how this virus is transmitted through mosquito species, the research seeks to understand the factors that may contribute to severe disease cases and long-term health complications in affected children. The findings could help identify gaps in diagnosis and inform future prevention strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are children under the age of 16 living in the Appalachian and Midwest regions of the United States, particularly those who may have been exposed to Aedes mosquitoes.

Not a fit: Patients outside of the age range or geographic areas affected by La Crosse virus may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of La Crosse virus infections, potentially reducing the incidence of severe neurological complications in children.

How similar studies have performed: Previous research has successfully identified and characterized other arboviral pathogens, suggesting that this approach may yield valuable insights into La Crosse virus as well.

Where this research is happening

Blacksburg, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.